![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 1, 651-656, January 7, 2000
From the AML1 is one of the most frequently
translocated genes in human leukemia. Here we demonstrate that acute
myeloid leukemia-1 (AML-1) (Runx-1) represses transcription from a
native promoter, p21Waf1/Cip1. Unexpectedly, this repression
did not require interactions with the Groucho co-repressor. To define
the mechanism of repression, we asked whether other co-repressors could
interact with AML-1. We demonstrate that AML-1 interacts with the mSin3
co-repressors. Moreover, endogenous AML-1 associated with endogenous
mSin3A in mammalian cells. A deletion mutant of AML-1 that did not
interact with mSin3A failed to repress transcription. The AML-1/mSin3
association suggests a mechanism of repression for the chromosomal
translocation fusion proteins that disrupt AML-1.
A Mechanism of Repression by Acute Myeloid Leukemia-1, the Target
of Multiple Chromosomal Translocations in Acute Leukemia*
§¶,
§,
§,
,
§
Departments of Biochemistry and
Medicine, and the § Vanderbilt Cancer Center, Vanderbilt
University School of Medicine, Nashville, Tennessee 37232, the
Department of Biology, Bethel College,
North Newton, Kansas 67117, and the ** H. Lee Moffitt Cancer Center
and Research Institute, University of South Florida,
Tampa, Florida 33612
*
This work was supported in part by NCI Grants RO1-AG13726,
RO1-CA64140, and RO1-CA77274 from the National Institutes of Health, by
American Chemical Society Grants JFRA-591 (to S. W. H.) and F32-CA77167 (to J. J. W.), by Center Grant CA68485 from the NCI, National Institutes of Health, and by Grant MCB9631067 from the National Science Foundation (to E. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of
Biochemistry, Vanderbilt Cancer Center, Vanderbilt University School of
Medicine, Medical Research Bldg. II, Rm. 512, 23rd and Pierce, Nashville, TN 37232. Tel.: 615-936-3582; Fax: 615-936-1790; E-mail: scott.hiebert@mcmail.vanderbilt.edu.
This article has been cited by other articles:
![]() |
R. Bakshi, S. K. Zaidi, S. Pande, M. Q. Hassan, D. W. Young, M. Montecino, J. B. Lian, A. J. van Wijnen, J. L. Stein, and G. S. Stein The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes J. Cell Sci., December 1, 2008; 121(23): 3981 - 3990. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Berg, M. Fliegauf, J. Burger, M. S. Staege, S. Liu, N. Martinez, O. Heidenreich, S. Burdach, T. Haferlach, M. H. Werner, et al. Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO Haematologica, November 1, 2008; 93(11): 1728 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Wee, D. C.-C. Voon, S.-C. Bae, and Y. Ito PEBP2-{beta}/CBF-{beta}-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis Blood, November 1, 2008; 112(9): 3777 - 3787. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Satoh, I. Matsumura, H. Tanaka, S. Ezoe, K. Fukushima, M. Tokunaga, M. Yasumi, H. Shibayama, M. Mizuki, T. Era, et al. AML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem Cells J. Biol. Chem., October 31, 2008; 283(44): 30045 - 30056. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xu, W. Luo, D. J. Elzi, C. Grandori, and D. A. Galloway NFX1 Interacts with mSin3A/Histone Deacetylase To Repress hTERT Transcription in Keratinocytes Mol. Cell. Biol., August 1, 2008; 28(15): 4819 - 4828. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Marshall, A. C. Moore, M. Ohki, I. Kitabayashi, D. Patterson, and D. A. Ornelles RUNX1 Permits E4orf6-Directed Nuclear Localization of the Adenovirus E1B-55K Protein and Associates with Centers of Viral DNA and RNA Synthesis J. Virol., July 1, 2008; 82(13): 6395 - 6408. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ogawa, M. Satake, and K. Ikuta Physical and Functional Interactions between STAT5 and Runx Transcription Factors J. Biochem., May 1, 2008; 143(5): 695 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, V. Jankovic, A. Gural, G. Huang, A. Pardanani, S. Menendez, J. Zhang, R. Dunne, A. Xiao, H. Erdjument-Bromage, et al. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity Genes & Dev., March 1, 2008; 22(5): 640 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang and B. M. Peterlin Differential Chromatin Looping Regulates CD4 Expression in Immature Thymocytes Mol. Cell. Biol., February 1, 2008; 28(3): 907 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kilbey, K. Blyth, S. Wotton, A. Terry, A. Jenkins, M. Bell, L. Hanlon, E. R. Cameron, and J. C. Neil Runx2 Disruption Promotes Immortalization and Confers Resistance to Oncogene-Induced Senescence in Primary Murine Fibroblasts Cancer Res., December 1, 2007; 67(23): 11263 - 11271. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Motoda, M. Osato, N. Yamashita, B. Jacob, L. Q. Chen, M. Yanagida, H. Ida, H.-J. Wee, A. X. Sun, I. Taniuchi, et al. Runx1 Protects Hematopoietic Stem/Progenitor Cells from Oncogenic Insult Stem Cells, December 1, 2007; 25(12): 2976 - 2986. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Wildt, G. Sun, B. Grueter, M. Fischer, M. Zamisch, M. Ehlers, and R. Bosselut The Transcription Factor Zbtb7b Promotes CD4 Expression by Antagonizing Runx-Mediated Activation of the CD4 Silencer J. Immunol., October 1, 2007; 179(7): 4405 - 4414. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stewart, N. Mackay, L. Hanlon, K. Blyth, L. Scobie, E. Cameron, and J. C. Neil Insertional Mutagenesis Reveals Progression Genes and Checkpoints in MYC/Runx2 Lymphomas Cancer Res., June 1, 2007; 67(11): 5126 - 5133. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Peterson, M. Yan, and D.-E. Zhang The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO Blood, May 15, 2007; 109(10): 4392 - 4398. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Starkova, J. Madzo, G. Cario, T. Kalina, A. Ford, M. Zaliova, O. Hrusak, and J. Trka The Identification of (ETV6)/RUNX1-Regulated Genes in Lymphopoiesis Using Histone Deacetylase Inhibitors in ETV6/RUNX1-Positive Lymphoid Leukemic Cells Clin. Cancer Res., March 15, 2007; 13(6): 1726 - 1735. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wichmann, L. Chen, M. Heinrich, D. Baus, E. Pfitzner, M. Zornig, O. G. Ottmann, and M. Grez Targeting the Oligomerization Domain of ETO Interferes with RUNX1/ETO Oncogenic Activity in t(8;21)-Positive Leukemic Cells Cancer Res., March 1, 2007; 67(5): 2280 - 2289. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Biggs, L. F. Peterson, Y. Zhang, A. S. Kraft, and D.-E. Zhang AML1/RUNX1 Phosphorylation by Cyclin-Dependent Kinases Regulates the Degradation of AML1/RUNX1 by the Anaphase-Promoting Complex Mol. Cell. Biol., October 15, 2006; 26(20): 7420 - 7429. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Choi, K. E. Elagib, L. L. Delehanty, and A. N. Goldfarb Erythroid Inhibition by the Leukemic Fusion AML1-ETO Is Associated with Impaired Acetylation of the Major Erythroid Transcription Factor GATA-1. Cancer Res., March 15, 2006; 66(6): 2990 - 2996. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, F. Zhang, T. Kurosu, and B. M. Peterlin Runx1 Binds Positive Transcription Elongation Factor b and Represses Transcriptional Elongation by RNA Polymerase II: Possible Mechanism of CD4 Silencing Mol. Cell. Biol., December 15, 2005; 25(24): 10675 - 10683. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Moreno-Miralles, L. Pan, J. Keates-Baleeiro, K. Durst-Goodwin, C. Yang, H.-G. Kim, M. A. Thompson, C. A. Klug, J. L. Cleveland, and S. W. Hiebert The inv(16) Cooperates with ARF Haploinsufficiency to Induce Acute Myeloid Leukemia J. Biol. Chem., December 2, 2005; 280(48): 40097 - 40103. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Z. Chi, J.-O. Yang, K.-Y. Lee, K. Ito, C. Sakakura, Q.-L. Li, H.-R. Kim, E.-J. Cha, Y.-H. Lee, A. Kaneda, et al. RUNX3 Suppresses Gastric Epithelial Cell Growth by Inducing p21WAF1/Cip1 Expression in Cooperation with Transforming Growth Factor {beta}-Activated SMAD Mol. Cell. Biol., September 15, 2005; 25(18): 8097 - 8107. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hirai, I. M Samokhvalov, T. Fujimoto, S. Nishikawa, J. Imanishi, and S.-I. Nishikawa Involvement of Runx1 in the down-regulation of fetal liver kinase-1 expression during transition of endothelial cells to hematopoietic cells Blood, September 15, 2005; 106(6): 1948 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yang, W. Khalaf, L. van de Locht, J. H. Jansen, M. Gao, M. A. Thompson, B. A. van der Reijden, D. H. Gutmann, R. Delwel, D. W. Clapp, et al. Transcriptional Repression of the Neurofibromatosis-1 Tumor Suppressor by the t(8;21) Fusion Protein Mol. Cell. Biol., July 15, 2005; 25(14): 5869 - 5879. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Biggs, Y. Zhang, L. F. Peterson, M. Garcia, D.-E. Zhang, and A. S. Kraft Phosphorylation of AML1/RUNX1 Regulates Its Degradation and Nuclear Matrix Association Mol. Cancer Res., July 1, 2005; 3(7): 391 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Gartel and S. K. Radhakrishnan Lost in Transcription: p21 Repression, Mechanisms, and Consequences Cancer Res., May 15, 2005; 65(10): 3980 - 3985. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-I. Trompeter, N. Gomez-Lozano, S. Santourlidis, B. Eisermann, P. Wernet, C. Vilches, and M. Uhrberg Three Structurally and Functionally Divergent Kinds of Promoters Regulate Expression of Clonally Distributed Killer Cell Ig-Like Receptors (KIR), of KIR2DL4, and of KIR3DL3 J. Immunol., April 1, 2005; 174(7): 4135 - 4143. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kawazu, T. Asai, M. Ichikawa, G. Yamamoto, T. Saito, S. Goyama, K. Mitani, K. Miyazono, S. Chiba, S. Ogawa, et al. Functional Domains of Runx1 Are Differentially Required for CD4 Repression, TCR{beta} Expression, and CD4/8 Double-Negative to CD4/8 Double-Positive Transition in Thymocyte Development J. Immunol., March 15, 2005; 174(6): 3526 - 3533. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Mulloy, V. Jankovic, M. Wunderlich, R. Delwel, J. Cammenga, O. Krejci, H. Zhao, P. J. M. Valk, B. Lowenberg, and S. D. Nimer AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion PNAS, March 15, 2005; 102(11): 4016 - 4021. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Howcroft, J. D. Weissman, A. Gegonne, and D. S. Singer A T Lymphocyte-Specific Transcription Complex Containing RUNX1 Activates MHC Class I Expression J. Immunol., February 15, 2005; 174(4): 2106 - 2115. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yoshida, T. Ogata, K. Tanabe, S. Li, M. Nakazato, K. Kohu, T. Takafuta, S. Shapiro, Y. Ohta, M. Satake, et al. Filamin A-Bound PEBP2{beta}/CBF{beta} Is Retained in the Cytoplasm and Prevented from Functioning as a Partner of the Runx1 Transcription Factor Mol. Cell. Biol., February 1, 2005; 25(3): 1003 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Nguyen, P. P. Pandolfi, Y. Aikawa, Y. Tagata, M. Ohki, and I. Kitabayashi Physical and functional link of the leukemia-associated factors AML1 and PML Blood, January 1, 2005; 105(1): 292 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, J. R. Biggs, and A. S. Kraft Phorbol Ester Treatment of K562 Cells Regulates the Transcriptional Activity of AML1c through Phosphorylation J. Biol. Chem., December 17, 2004; 279(51): 53116 - 53125. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Planaguma, M. Diaz-Fuertes, A. Gil-Moreno, M. Abal, M. Monge, A. Garcia, T. Baro, T. M. Thomson, J. Xercavins, F. Alameda, et al. A Differential Gene Expression Profile Reveals Overexpression of RUNX1/AML1 in Invasive Endometrioid Carcinoma Cancer Res., December 15, 2004; 64(24): 8846 - 8853. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yan, S. A. Burel, L. F. Peterson, E. Kanbe, H. Iwasaki, A. Boyapati, R. Hines, K. Akashi, and D.-E. Zhang From the Cover: Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development PNAS, December 7, 2004; 101(49): 17186 - 17191. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goyama, Y. Yamaguchi, Y. Imai, M. Kawazu, M. Nakagawa, T. Asai, K. Kumano, K. Mitani, S. Ogawa, S. Chiba, et al. The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region Blood, December 1, 2004; 104(12): 3558 - 3564. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Schroeder, R. A. Kahler, X. Li, and J. J. Westendorf Histone Deacetylase 3 Interacts with Runx2 to Repress the Osteocalcin Promoter and Regulate Osteoblast Differentiation J. Biol. Chem., October 1, 2004; 279(40): 41998 - 42007. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bertrand-Philippe, R. G. Ruddell, M. J. P. Arthur, J. Thomas, N. Mungalsingh, and D. A. Mann Regulation of Tissue Inhibitor of Metalloproteinase 1 Gene Transcription by RUNX1 and RUNX2 J. Biol. Chem., June 4, 2004; 279(23): 24530 - 24539. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Asakura, H. Uchida, H. Miyachi, H. Kobayashi, Y. Miyakawa, S. D. Nimer, H. Takahashi, Y. Ikeda, and M. Kizaki TEL/AML1 Overcomes Drug Resistance Through Transcriptional Repression of Multidrug Resistance-1 Gene Expression Mol. Cancer Res., June 1, 2004; 2(6): 339 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Selvamurugan, S. Kwok, T. Alliston, M. Reiss, and N. C. Partridge Transforming Growth Factor-{beta}1 Regulation of Collagenase-3 Expression in Osteoblastic Cells by Cross-talk between the Smad and MAPK Signaling Pathways and Their Components, Smad2 and Runx2 J. Biol. Chem., April 30, 2004; 279(18): 19327 - 19334. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamaguchi, M. Kurokawa, Y. Imai, K. Izutsu, T. Asai, M. Ichikawa, G. Yamamoto, E. Nitta, T. Yamagata, K. Sasaki, et al. AML1 Is Functionally Regulated through p300-mediated Acetylation on Specific Lysine Residues J. Biol. Chem., April 9, 2004; 279(15): 15630 - 15638. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Telfer, E. E. Hedblom, M. K. Anderson, M. N. Laurent, and E. V. Rothenberg Localization of the Domains in Runx Transcription Factors Required for the Repression of CD4 in Thymocytes J. Immunol., April 1, 2004; 172(7): 4359 - 4370. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Hedvat, J. Yao, R. A. Sokolic, and S. D. Nimer Myeloid ELF1-like Factor Is a Potent Activator of Interleukin-8 Expression in Hematopoietic Cells J. Biol. Chem., February 20, 2004; 279(8): 6395 - 6400. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Imai, M. Kurokawa, Y. Yamaguchi, K. Izutsu, E. Nitta, K. Mitani, M. Satake, T. Noda, Y. Ito, and H. Hirai The Corepressor mSin3A Regulates Phosphorylation-Induced Activation, Intranuclear Location, and Stability of AML1 Mol. Cell. Biol., February 1, 2004; 24(3): 1033 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nishimura, Y. Fukushima-Nakase, Y. Fujita, M. Nakao, S. Toda, N. Kitamura, T. Abe, and T. Okuda VWRPY motif-dependent and -independent roles of AML1/Runx1 transcription factor in murine hematopoietic development Blood, January 15, 2004; 103(2): 562 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Puig-Kroger, T. Sanchez-Elsner, N. Ruiz, E. J. Andreu, F. Prosper, U. B. Jensen, J. Gil, P. Erickson, H. Drabkin, Y. Groner, et al. RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements Blood, November 1, 2003; 102(9): 3252 - 3261. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. McCarthy, W.-Z. Chang, Y. Liu, and M. Centrella Runx2 Integrates Estrogen Activity in Osteoblasts J. Biol. Chem., October 31, 2003; 278(44): 43121 - 43129. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pratap, M. Galindo, S. K. Zaidi, D. Vradii, B. M. Bhat, J. A. Robinson, J.-Y. Choi, T. Komori, J. L. Stein, J. B. Lian, et al. Cell Growth Regulatory Role of Runx2 during Proliferative Expansion of Preosteoblasts Cancer Res., September 1, 2003; 63(17): 5357 - 5362. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Komine, K. Hayashi, W. Natsume, T. Watanabe, Y. Seki, N. Seki, R. Yagi, W. Sukzuki, H. Tamauchi, K. Hozumi, et al. The Runx1 Transcription Factor Inhibits the Differentiation of Naive CD4+ T Cells into the Th2 Lineage by Repressing GATA3 Expression J. Exp. Med., July 7, 2003; 198(1): 51 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. P. Bristow and P. Shore Transcriptional regulation of the human MIP-1{alpha} promoter by RUNX1 and MOZ Nucleic Acids Res., June 1, 2003; 31(11): 2735 - 2744. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Bjerregaard, J. Jurlander, P. Klausen, N. Borregaard, and J. B. Cowland The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow Blood, June 1, 2003; 101(11): 4322 - 4332. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Durst, B. Lutterbach, T. Kummalue, A. D. Friedman, and S. W. Hiebert The inv(16) Fusion Protein Associates with Corepressors via a Smooth Muscle Myosin Heavy-Chain Domain Mol. Cell. Biol., January 15, 2003; 23(2): 607 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Westendorf, S. K. Zaidi, J. E. Cascino, R. Kahler, A. J. van Wijnen, J. B. Lian, M. Yoshida, G. S. Stein, and X. Li Runx2 (Cbfa1, AML-3) Interacts with Histone Deacetylase 6 and Represses the p21CIP1/WAF1 Promoter Mol. Cell. Biol., November 15, 2002; 22(22): 7982 - 7992. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Mulloy, J. Cammenga, K. L. MacKenzie, F. J. Berguido, M. A. S. Moore, and S. D. Nimer The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells Blood, January 1, 2002; 99(1): 15 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Liu, S. Toyosawa, T. Furuichi, N. Kanatani, C. Yoshida, Y. Liu, M. Himeno, S. Narai, A. Yamaguchi, and T. Komori Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures J. Cell Biol., October 1, 2001; 155(1): 157 - 166. [Abstract] |